Top

International Urology and Nephrology

Published in:

07-11-2023 | Chronic Kidney Disease | Nephrology - Original Paper

Short or long sleep duration was associated with chronic kidney disease in a Chinese nationwide cohort study

Authors: Naling Peng, Shizhen Li

Published in: International Urology and Nephrology | Issue 5/2024

Abstract

Objective

Sleep duration is an important factor influencing health outcomes. The association between sleep duration and kidney function remains elusive. This study aimed to explore the association between sleep duration and chronic kidney disease (CKD) amongst Chinese adults.

Methods

We conducted a cross-sectional study based on the China Health and Nutrition Survey (CHNS) in the wave of 2009. Participants were divided into three groups: ≤ 6 h/day (short sleepers), 7–8 h/day (regular sleepers) and ≥ 9 h/day (long sleepers) according to self-reported sleep duration. CKD was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m².

Results

A total of 8096 Chinese adults (45.9% men) with a mean age of 50.6 years were included in the study. Compared with regular sleepers, both short and long regular sleepers had a higher prevalence of CKD. A U-shaped relationship between sleep duration and CKD was displayed by restricted cubic spline curve (P-overall < 0.001, P-nonlinear < 0.001). Multivariate logistic regression models revealed that both short and long sleep duration were clinically associated with higher odds of CKD, after adjustments for covariates [adjusted odds ratio (OR) 1.25 and 1.30; 95% confidence interval (CI) 1.00–1.56 and 1.08–1.54, for short and long sleep duration, respectively]. In subgroup analyses, we found the association was still observed in participants without hypertension or diabetes mellitus.

Conclusion

Short or long sleep duration was associated with CKD in the general population.

Glassock RJ, Warnock DG, Delanaye P (2017) The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 13(2):104–114. https://doi.org/10.1038/nrneph.2016.163CrossRefPubMed

Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, Chen N, Zhang JE, Hu Z, Liu F, Hong D, Ma L, Liu H, Zhou X, Chen J, Pan L, Chen W, Wang W, Li X, Wang H (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822. https://doi.org/10.1016/S0140-6736(12)60033-6CrossRefPubMed

Fletcher BR, Damery S, Aiyegbusi OL, Anderson N, Calvert M, Cockwell P, Ferguson J, Horton M, Paap M, Sidey-Gibbons C, Slade A, Turner N, Kyte D (2022) Symptom burden and health-related quality of life in chronic kidney disease: a global systematic review and meta-analysis. PLOS MED 19(4):e1003954. https://doi.org/10.1371/journal.pmed.1003954CrossRefPubMedPubMedCentral

Evans M, Lewis RD, Morgan AR, Whyte MB, Hanif W, Bain SC, Davies S, Dashora U, Yousef Z, Patel DC, Strain WD (2022) A Narrative review of chronic kidney disease in clinical practice: current challenges and future perspectives. Adv Ther 39(1):33–43. https://doi.org/10.1007/s12325-021-01927-zCrossRefPubMed

Barrera-Chimal J, Girerd S, Jaisser F (2019) Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis. Kidney Int 96(2):302–319. https://doi.org/10.1016/j.kint.2019.02.030CrossRefPubMed

Turek NF, Ricardo AC, Lash JP (2012) Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis 60(5):823–833. https://doi.org/10.1053/j.ajkd.2012.04.027CrossRefPubMedPubMedCentral

Lane JM, Qian J, Mignot E, Redline S, Scheer F, Saxena R (2023) Genetics of circadian rhythms and sleep in human health and disease. Nat Rev Genet 24(1):4–20. https://doi.org/10.1038/s41576-022-00519-zCrossRefPubMed

St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL (2016) Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American heart association. Circulation 134(18):e367–e386. https://doi.org/10.1161/CIR.0000000000000444CrossRefPubMedPubMedCentral

Tobaldini E, Fiorelli EM, Solbiati M, Costantino G, Nobili L, Montano N (2019) Short sleep duration and cardiometabolic risk: from pathophysiology to clinical evidence. Nat Rev Cardiol 16(4):213–224. https://doi.org/10.1038/s41569-018-0109-6CrossRefPubMed

10.

Li J, Cao D, Huang Y, Chen Z, Wang R, Dong Q, Wei Q, Liu L (2022) Sleep duration and health outcomes: an umbrella review. Sleep Breath 26(3):1479–1501. https://doi.org/10.1007/s11325-021-02458-1CrossRefPubMed

11.

Antza C, Kostopoulos G, Mostafa S, Nirantharakumar K, Tahrani A (2021) The links between sleep duration, obesity and type 2 diabetes mellitus. J Endocrinol 252(2):125–141. https://doi.org/10.1530/JOE-21-0155CrossRefPubMedPubMedCentral

12.

García-Perdomo HA, Zapata-Copete J, Rojas-Cerón CA (2019) Sleep duration and risk of all-cause mortality: a systematic review and meta-analysis. Epidemiol Psychiatr Sci 28(5):578–588. https://doi.org/10.1017/S2045796018000379CrossRefPubMed

13.

Hao Q, Xie M, Zhu L, Dou Y, Dai M, Wu Y, Tang X, Wang Q (2020) Association of sleep duration with chronic kidney disease and proteinuria in adults: a systematic review and dose-response meta-analysis. Int Urol Nephrol 52(7):1305–1320. https://doi.org/10.1007/s11255-020-02488-wCrossRefPubMed

14.

Sun H, Qin K, Zou C, Wang HH, Lu C, Chen W, Guo VY (2021) The association of nighttime sleep duration and quality with chronic kidney disease in middle-aged and older Chinese: a cohort study. Sleep Med 86:25–31. https://doi.org/10.1016/j.sleep.2021.08.007CrossRefPubMed

15.

Jiang L, Xu H (2023) U-shaped relationship between sleep duration and CKD in US adults: data from national health and nutrition examination survey (NHANES) 2005–2014. Am J Nephrol. https://doi.org/10.1159/000531440CrossRefPubMed

16.

Petrov ME, Buman MP, Unruh ML, Baldwin CM, Jeong M, Reynaga-Ornelas L, Youngstedt SD (2016) Association of sleep duration with kidney function and albuminuria: NHANES 2009–2012. Sleep Health 2(1):75–81. https://doi.org/10.1016/j.sleh.2015.12.003CrossRefPubMedPubMedCentral

17.

Kim CW, Chang Y, Sung E, Yun KE, Jung HS, Ko BJ, Kwon MJ, Hyun YY, Lee KB, Kim H, Shin H, Ryu S (2017) Sleep duration and quality in relation to chronic kidney disease and glomerular hyperfiltration in healthy men and women. PLoS ONE 12(4):e0175298. https://doi.org/10.1371/journal.pone.0175298CrossRefPubMedPubMedCentral

18.

Cheungpasitporn W, Thongprayoon C, Gonzalez-Suarez ML, Srivali N, Ungprasert P, Kittanamongkolchai W, Caples SM, Erickson SB (2017) The effects of short sleep duration on proteinuria and chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant 32(6):991–996. https://doi.org/10.1093/ndt/gfw072CrossRefPubMed

19.

Popkin BM, Du S, Zhai F, Zhang B (2010) Cohort profile: the China health and nutrition survey–monitoring and understanding socio-economic and health change in China, 1989–2011. INT J EPIDEMIOL 39(6):1435–1440. https://doi.org/10.1093/ije/dyp322CrossRefPubMed

20.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006CrossRefPubMedPubMedCentral

21.

K/DOQI clinical practice guidelines for chronic kidney disease (2002) evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-266

22.

Watson NF, Badr MS, Belenky G, Bliwise DL, Buxton OM, Buysse D, Dinges DF, Gangwisch J, Grandner MA, Kushida C, Malhotra RK, Martin JL, Patel SR, Quan SF, Tasali E (2015) Recommended amount of sleep for a healthy adult: a joint consensus statement of the American academy of sleep medicine and sleep research society. Sleep 38(6):843–844. https://doi.org/10.5665/sleep.4716CrossRefPubMedPubMedCentral

23.

Fujibayashi K, Fukuda H, Yokokawa H, Haniu T, Oka F, Ooike M, Gunji T, Sasabe N, Okumura M, Iijima K, Hisaoka T, Isonuma H (2012) Associations between healthy lifestyle behaviors and proteinuria and the estimated glomerular filtration rate (eGFR). J Atheroscler Thromb 19(10):932–940. https://doi.org/10.5551/jat.12781CrossRefPubMed

24.

Sasaki S, Yoshioka E, Saijo Y, Kita T, Tamakoshi A, Kishi R (2014) Short sleep duration increases the risk of chronic kidney disease in shift workers. J Occup Environ Med 56(12):1243–1248. https://doi.org/10.1097/JOM.0000000000000322CrossRefPubMed

25.

Yamamoto R, Shinzawa M, Isaka Y, Yamakoshi E, Imai E, Ohashi Y, Hishida A (2018) Sleep quality and sleep duration with CKD are associated with progression to ESKD. Clin J Am Soc Nephrol 13(12):1825–1832. https://doi.org/10.2215/CJN.01340118CrossRefPubMedPubMedCentral

26.

Salifu I, Tedla F, Pandey A, Ayoub I, Brown C, McFarlane SI, Jean-Louis G (2014) Sleep duration and chronic kidney disease: analysis of the national health interview survey. Cardiorenal Med 4(3–4):210–216. https://doi.org/10.1159/000368205CrossRefPubMedPubMedCentral

27.

Ogna A, Forni OV, Haba RJ, Tobback N, Andries D, Preisig M, Tafti M, Vollenweider P, Waeber G, Marques-Vidal P, Heinzer R (2016) Sleep characteristics in early stages of chronic kidney disease in the hypnolaus cohort. Sleep 39(4):945–953. https://doi.org/10.5665/sleep.5660CrossRefPubMedPubMedCentral

28.

Guo X, Yu S, Li Z, Guo L, Zheng L, Yang H, Zou L, Hu W, Zhou Y, Zhu L, Zhang Y, Sun Y (2015) Self-reported sleep duration is associated with reduced glomerular filtration rate among adults with hypertension: a population-based study from rural northeast China. J Sleep Res 24(3):351–358. https://doi.org/10.1111/jsr.12274CrossRefPubMed

29.

Park S, Lee S, Kim Y, Lee Y, Kang MW, Kim K, Kim YC, Han SS, Lee H, Lee JP, Joo KW, Lim CS, Kim YS, Kim DK (2020) Short or Long sleep duration and CKD: a mendelian randomization study. J Am Soc Nephrol 31(12):2937–2947. https://doi.org/10.1681/ASN.2020050666CrossRefPubMedPubMedCentral

30.

Li K, Zhao J, Yang W, Ye Z (2023) Sleep traits and risk of end-stage renal disease: a mendelian randomization study. BMC Med Genomics 16(1):76. https://doi.org/10.1186/s12920-023-01497-9CrossRefPubMedPubMedCentral

31.

Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y (2018) Long sleep duration and health outcomes: a systematic review, meta-analysis and meta-regression. Sleep Med Rev 39:25–36. https://doi.org/10.1016/j.smrv.2017.06.011CrossRefPubMed

32.

Itani O, Jike M, Watanabe N, Kaneita Y (2017) Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med 32:246–256. https://doi.org/10.1016/j.sleep.2016.08.006CrossRefPubMed

33.

Seravalle G, Mancia G, Grassi G (2018) Sympathetic nervous system, sleep, and hypertension. Curr Hypertens Rep 20(9):74. https://doi.org/10.1007/s11906-018-0874-yCrossRefPubMed

34.

Davies SK, Ang JE, Revell VL, Holmes B, Mann A, Robertson FP, Cui N, Middleton B, Ackermann K, Kayser M, Thumser AE, Raynaud FI, Skene DJ (2014) Effect of sleep deprivation on the human metabolome. Proc Natl Acad Sci USA 111(29):10761–10766. https://doi.org/10.1073/pnas.1402663111CrossRefPubMedPubMedCentral

35.

Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM (2004) Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 43(4):678–683. https://doi.org/10.1016/j.jacc.2003.07.050CrossRefPubMed

36.

Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, Redline S (2009) Sleep duration and biomarkers of inflammation. Sleep 32(2):200–204. https://doi.org/10.1093/sleep/32.2.200CrossRefPubMedPubMedCentral

37.

Dowd JB, Goldman N, Weinstein M (2011) Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol 21(11):799–806. https://doi.org/10.1016/j.annepidem.2011.07.004CrossRefPubMedPubMedCentral

Title: Short or long sleep duration was associated with chronic kidney disease in a Chinese nationwide cohort study
Authors: Naling Peng
Shizhen Li
Publication date: 07-11-2023
Publisher: Springer Netherlands
Keywords: Chronic Kidney Disease
Diabetes
Hypertension
Hypertension
Published in: International Urology and Nephrology / Issue 5/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-023-03861-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2024

Enzyme-induced hypoxia leads to inflammation in urothelial cells in vitro

Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expulsive therapy for distal ureteric stones

Evaluation of N-acetyl-β-D-glucosaminidase as a prognostic marker for diabetic nephropathy in type 2 diabetics: systematic review and meta-analysis

Response letter

Natural history of renal angiomyolipoma in a high-volume center: our experience during more than 15 years of follow up

Mesial temporal atrophy in preoperative MRI rather than steep Trendelenburg position is associated with postoperative delirium in patients undergoing a major urologic surgery

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials